DXRX, the platform that connects the precision medicine industry

Home > Case Studies > The platform for precision medicine

The challenge

Precision medicine makes it possible to find the right treatment for each patient; the players in this field do not communicate well with each other.

The solution

The creation of the first precision medicine network.

53

countries covered in the world.

26M€

invested in the project.

2500

connected laboratories.

The origin of the platform

Conception

Diaceutics PLC announced DXRX, the world's first diagnostic network for precision medicine, in 2020, which will enable the company to expand its business to meet the rapidly growing demand in the precision medicine market. It represents the culmination of a $28 million investment by Diaceutics in software and data.

By connecting laboratories and diagnostic companies, the sector's players collaborate fluidly and securely to enable sick patients to receive the right treatment more quickly.
By creating the world's first precision medicine network, a revolution is taking place in the digitalization of the medical sector.

Diaceutics launched DXRX, the world’s largest network for precision medicine. 26 million euros raised for the project.

Partager l’article
Share